Dupilumab Reduces Blood Levels, Allergen-Specific IgE in Atopic Dermatitis PatientsNovember 5th 2021
Data from the LIBERTY AD ADOL trial showed that adolescent patients with moderate-to-severe atopic dermatitis treated with the biologic reported decreases in total and allergen-specific IgE levels for cat dander, peanuts, and more.
African Americans, Hispanics Poorly Represented in Asthma Clinical TrialsNovember 21st 2018
Many trials for monoclonal antibody therapies for asthma reported small percentages of African American or Hispanic participants, and some didn’t report racial/ethnic demographics at all.
Oral Drug Desensitizes Pediatric Peanut Allergies, Nears FDA ConsiderationNovember 19th 2018
The AR101 oral therapy—a biologic designed to desensitize peanut allergies, manufactured by Aimmune Therapeutics—is anticipated to be submitted for FDA approval in the next month.